115 related articles for article (PubMed ID: 12916296)
21. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
[TBL] [Abstract][Full Text] [Related]
22. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL.
Bord S; Frith E; Ireland DC; Scott MA; Craig JI; Compston JE
Bone; 2005 May; 36(5):812-9. PubMed ID: 15794927
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.
Kubota A; Hasegawa K; Suguro T; Koshihara Y
J Rheumatol; 2004 Mar; 31(3):426-35. PubMed ID: 14994384
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells.
Figueroa JD; Hayman MJ
Exp Cell Res; 2004 Jun; 296(2):163-72. PubMed ID: 15149847
[TBL] [Abstract][Full Text] [Related]
25. [Transduction of recombinant marrow stem cells using lentiviral vector and adenoviral vector: a comparative study].
Ma XS; Jiang JY; Lü FZ; Ma X; Li XK; Huang HY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3340-4. PubMed ID: 17313830
[TBL] [Abstract][Full Text] [Related]
26. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
27. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat.
Li JZ; Li H; Sasaki T; Holman D; Beres B; Dumont RJ; Pittman DD; Hankins GR; Helm GA
Gene Ther; 2003 Sep; 10(20):1735-43. PubMed ID: 12939640
[TBL] [Abstract][Full Text] [Related]
28. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.
Kostenuik PJ; Bolon B; Morony S; Daris M; Geng Z; Carter C; Sheng J
Bone; 2004 Apr; 34(4):656-64. PubMed ID: 15050896
[TBL] [Abstract][Full Text] [Related]
29. Synergistic enhancement of new bone formation by recombinant human bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis: a pilot study in dogs.
Yao Y; Wang G; Wang Z; Wang C; Zhang H; Liu C
J Oral Maxillofac Surg; 2011 Nov; 69(11):e446-55. PubMed ID: 22018252
[TBL] [Abstract][Full Text] [Related]
30. Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli.
Long S; Truong L; Bennett K; Phillips A; Wong-Staal F; Ma H
Protein Expr Purif; 2006 Apr; 46(2):374-8. PubMed ID: 16298141
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen.
Bord S; Frith E; Ireland DC; Scott MA; Craig JI; Compston JE
Br J Haematol; 2004 Jul; 126(2):244-51. PubMed ID: 15238146
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression.
Wan M; Shi X; Feng X; Cao X
J Biol Chem; 2001 Mar; 276(13):10119-25. PubMed ID: 11139569
[TBL] [Abstract][Full Text] [Related]
33. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
34. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis.
Lories RJ; Derese I; Ceuppens JL; Luyten FP
Arthritis Rheum; 2003 Oct; 48(10):2807-18. PubMed ID: 14558086
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo induction of bone formation based on ex vivo gene therapy using rat adipose-derived adult stem cells expressing BMP-7.
Yang M; Ma QJ; Dang GT; Ma Kt; Chen P; Zhou CY
Cytotherapy; 2005; 7(3):273-81. PubMed ID: 16081354
[TBL] [Abstract][Full Text] [Related]
36. Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint.
Carda C; Silvestrini G; Gomez de Ferraris ME; Peydró A; Bonucci E
Tissue Cell; 2005 Jun; 37(3):247-55. PubMed ID: 15899507
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
38. Implication of prostaglandin receptors in the accumulation of osteoprotegerin in human osteoblast cultures.
Samadfam R; Gallant MA; Miousse MC; Parent JL; de Brum-Fernandes AJ
J Rheumatol; 2006 Jun; 33(6):1167-75. PubMed ID: 16755666
[TBL] [Abstract][Full Text] [Related]
39. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
[TBL] [Abstract][Full Text] [Related]
40. [Effects of 1,25-dihydroxyvitamin D3 on the expressions of osteoprotegerin and receptor activator of NF-kappaB ligand in mouse osteoblasts].
Tian QX; Huang GY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):418-22. PubMed ID: 15379268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
